VisionCare Anticipates Big Boost From Expanded Telescope Implant Indication
This article was originally published in The Gray Sheet
Executive Summary
FDA approved VisionCare Ophthalmic Technologies’ Implantable Miniature Telescope to treat macular degeneration in 65- to 74-year-old patients, expanding on the original 75-and-older indication and growing the potential market by about a third.